Data as of Nov 28
| +0.45 / +1.97%|
The 8 analysts offering 12-month price forecasts for Exone Co have a median target of 22.50, with a high estimate of 44.00 and a low estimate of 18.00. The median estimate represents a -3.60% decrease from the last price of 23.34.
The current consensus among 11 polled investment analysts is to Hold stock in Exone Co. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.